BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sotirakopoulos N, Athanasiou G, Tsitsios T, Mavromatidis K. The influence of l-carnitine supplementation on hematocrit and hemoglobin levels in patients with end stage renal failure on CAPD. Ren Fail. 2002;24:505-510. [PMID: 12212830 DOI: 10.1081/jdi-120006777] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Kaneko S, Yanai K, Kitano T, Miyazawa H, Hirai K, Ookawara S, Morishita Y. Change in Anemia by Carnitine Supplementation in Patients Undergoing Peritoneal Dialysis: A Retrospective Observational Study. Front Med (Lausanne) 2021;8:767945. [PMID: 34805230 DOI: 10.3389/fmed.2021.767945] [Reference Citation Analysis]
2 Strasser A, Dedoyard A, Lohninger A, Niedermüller H. L-Carnitine L-tartrate (LCLT) and dehydroepiandrosterone sulfate (DHEAS) affect red and white blood cells in aged Sprague-Dawley rats. Arch Gerontol Geriatr 2007;44:325-36. [PMID: 16930745 DOI: 10.1016/j.archger.2006.07.003] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Bonomini M, Di Liberato L, Zammit V, Arduini A. Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis. Molecules 2019;24:E3449. [PMID: 31547545 DOI: 10.3390/molecules24193449] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
4 Malaguarnera M, Vacante M, Giordano M, Motta M, Bertino G, Pennisi M, Neri S, Malaguarnera M, Volti GL, Galvano F. L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. World J Gastroenterol 2011; 17(39): 4414-4420 [PMID: 22110268 DOI: 10.3748/wjg.v17.i39.4414] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
5 Sato S, Moriya K, Furukawa M, Saikawa S, Namisaki T, Kitade M, Kawaratani H, Kaji K, Takaya H, Shimozato N, Sawada Y, Seki K, Kitagawa K, Akahane T, Mitoro A, Okura Y, Yamao J, Yoshiji H. Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection. Clin Mol Hepatol 2019;25:65-73. [PMID: 30798587 DOI: 10.3350/cmh.2018.0070] [Reference Citation Analysis]
6 Takashima H, Maruyama T, Abe M. Significance of Levocarnitine Treatment in Dialysis Patients. Nutrients 2021;13:1219. [PMID: 33917145 DOI: 10.3390/nu13041219] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shimizu S, Takashima H, Tei R, Furukawa T, Okamura M, Kitai M, Nagura C, Maruyama T, Higuchi T, Abe M. Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Peritoneal Dialysis. Nutrients 2019;11:E2645. [PMID: 31689941 DOI: 10.3390/nu11112645] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]